SPECIAL NOTICE
65 -- Notice of Intent to use Other than full and open competition for procurement of Over The Counter (OTC) COVID-19 Tests
- Notice Date
- 9/21/2023 12:15:43 PM
- Notice Type
- Justification
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- ASPR/DAAPPO/ORM HQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- ASPR09012023
- Archive Date
- 10/21/2023
- Point of Contact
- Mary Masamo
- E-Mail Address
-
IBMSCC-Submissions@hhs.gov
(IBMSCC-Submissions@hhs.gov)
- Award Number
- 75A50223C00034-75A50223C00035-75A50223C00036-75A50223C00037-75A50223C00038-75A50223C00039-75A50223C00040-75A50223C00041-75A50223C00042-75A50223C00043-75A50223C00044-75A50223C00045-75A50223C00046-75A50223C00048
- Award Date
- 09/20/2023
- Description
- The Department of Health and Human Services (DHHS), Administration for Strategic Preparedness and Response (ASPR) intends on issuing 13 contracts, on or about 09/15/2023, to domestic manufacturers of Over the Counter (OTC) COVID-19 tests, in accordance with 41 U.S.C. 3304(a)(3)(A) and FAR 6.302-3(a)(2)(i). See attached for additional details, including minimum requirements and delivery locations. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. If interested in obtaining a copy of the solicitation, send an email to: ibmscc-submissions@hhs.gov. Organization: DHHS/ASPR Contracting Office Address: 400 7th Street, SW, Washington, DC Contracting Office Zip Code: 20024 Product or Service Code (PSC): 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing� Place of Performance: Contractor facility Procedures to be used in awarding the contracts: Direct written solicitations The above notice is an updated notice to add an additional vendor that was included in the award. The updated notice is applicable to the updated Justification and Approval. Nothing else has changed in the updated Justification and approval. The Department of Health and Human Services (DHHS), Administration for Strategic Preparedness and Response (ASPR) intends on issuing 14 contracts, on or about 09/15/2023, to domestic manufacturers of Over the Counter (OTC) COVID-19 tests, in accordance with 41 U.S.C. 3304(a)(3)(A) and FAR 6.302-3(a)(2)(i). See attached for additional details, including minimum requirements and delivery locations. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. If interested in obtaining a copy of the solicitation, send an email to: ibmscc-submissions@hhs.gov. The Government intends to make awards to known viable and capable domestic manufacturers that meet all the government requirements, based on market research and responses received to the posted synopses�. Organization: DHHS/ASPR Contracting Office Address: 400 7th Street, SW, Washington, DC Contracting Office Zip Code: 20024 Product or Service Code (PSC): 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing� Place of Performance: Contractor facility Procedures to be used in awarding the contracts: Direct written solicitations
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/cc5c25e7c91c46cfa7314dcc17407c04/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06840362-F 20230923/230921230528 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |